Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

Reduced oxygen levels (hypoxia) is one of the most important factors influencing clinical
outcome after radiotherapy. This is primarily because hypoxic cells are resistant to radiation …

Tumor hypoxia is a well-established biological phenomenon that affects the curability of
solid tumors, regardless of treatment modality. Especially for head and neck cancer patients …

Hypoxia, a hallmark of most solid tumours, is a negative prognostic factor due to its
association with an aggressive tumour phenotype and therapeutic resistance. Given its …

Oxygen deprivation (hypoxia) in non–small cell lung cancer (NSCLC) is an important factor
in treatment resistance and poor survival. Hypoxia is an attractive therapeutic target …

Diffusion-weighted (DW) magnetic resonance (MR) imaging is emerging as a powerful
clinical tool for directing the care of patients with cancer. Whole-body DW imaging is almost …

PURPOSE: To explore in a prospective trial the prognostic value of hypoxia imaging before
and during radiochemotherapy in patients with locally advanced head and neck cancer …

Dose painting is the prescription of a nonuniform radiation dose distribution to the target
volume based on functional or molecular images shown to indicate the local risk of relapse …

Over the last few decades, significant improvements have been made in the radiotherapy
(RT) treatment of head and neck malignancies. The progressive introduction of intensity …

Magnetic resonance‐guided radiation therapy (MRgRT) is a promising approach to
improving clinical outcomes for patients treated with radiation therapy. The roles of image …